Literature DB >> 14638400

The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure.

Peter Vanlandschoot1, Tinghua Cao, Geert Leroux-Roels.   

Abstract

The hepatitis B virus nucleocapsid or core antigen is extremely immunogenic during infection and after immunization. This review summarizes several features of the nucleocapsid which explain this exceptionally high immunogenicity: a unique three-dimensional folding, the presence of a region that interacts with immunoglobulins outside the classical antibody-binding site, the presence of many CD4+ T cell epitopes, and the presence of encapsidated nucleic acids. Because of these features, nucleocapsids efficiently interact and activate antigen presenting cells, especially nai;ve B cells. This leads to the generation of a dominant Th1 immunity phenotype and the secretion of high levels of IgM and IgG anti-nucleocapsid antibodies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638400     DOI: 10.1016/j.antiviral.2003.08.011

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  18 in total

1.  Contamination of a recombinant hepatitis B virus nucleocapsid preparation with a human B-cell activator.

Authors:  Peter Vanlandschoot; Freya Van Houtte; Benedikte Serruys; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

2.  Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.

Authors:  Norman R Watts; Giovanni Cardone; Joe G Vethanayagam; Naiqian Cheng; Catharina Hultgren; Stephen J Stahl; Alasdair C Steven; Matti Sällberg; Paul T Wingfield
Journal:  J Mol Biol       Date:  2008-04-09       Impact factor: 5.469

3.  A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.

Authors:  Pierre-Louis Hervé; Mariam Raliou; Christiane Bourdieu; Catherine Dubuquoy; Agnès Petit-Camurdan; Nicolas Bertho; Jean-François Eléouët; Christophe Chevalier; Sabine Riffault
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

4.  Conservative Evolution of Hepatitis B Virus Precore and Core Gene During Immune Tolerant Phase in Intrafamilial Transmission.

Authors:  Yuqian Luo; Le Zhang; Yimin Dai; Yali Hu; Biyun Xu; Yi-Hua Zhou
Journal:  Virol Sin       Date:  2020-03-02       Impact factor: 4.327

5.  Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly.

Authors:  Hee Yong Kang; Seungkeun Lee; Sung Gyoo Park; Jaehoon Yu; Youngsoo Kim; Guhung Jung
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

6.  Cloning and characterization of a novel hepatitis B virus core binding protein C12.

Authors:  Yin-Ying Lu; Jun Cheng; Yong-Ping Yang; Yan Liu; Lin Wang; Ke Li; Ling-Xia Zhang
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

7.  Hepatitis B virus core interacts with the host cell nucleolar protein, nucleophosmin 1.

Authors:  Su Jin Lee; Hee Youn Shim; Antony Hsieh; Ji Young Min; Gu hung Jung
Journal:  J Microbiol       Date:  2010-02-04       Impact factor: 3.422

8.  Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencing.

Authors:  Maria Homs; Maria Buti; David Tabernero; Josep Quer; Alex Sanchez; Noelia Corral; Rafael Esteban; Francisco Rodriguez-Frias
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

9.  Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms.

Authors:  Xiaohua Ye; Zhiqiang Ku; Qingwei Liu; Xiaoli Wang; Jinping Shi; Yunfang Zhang; Liangliang Kong; Yao Cong; Zhong Huang
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

Review 10.  Atypical serological profiles in hepatitis B virus infection.

Authors:  Robério A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-29       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.